05.07.2017
- Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...
14.06.2017
- US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...
25.05.2017
- The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
24.05.2017
- Chemspec Europe 2017 is just around the corner: The 32nd edition of the International Exhibition for Fine and Speciality Chemicals takes place from 31 May – 1 June 2017 at the...
12.05.2017
- Chemspec Europe 2017 is the International Exhibition for Fine and Speciality Chemicals. From 31 May – 1 June 2017, about 390 exhibitors from 29 countries will meet at the Munich...
28.04.2017
- German pharmaceuticals and chemicals producer Merck is divesting its Biosimilars business to compatriot firm Fresenius Kabi, a unit of medical technology and healthcare group...
12.04.2017
- Less than two months to go until the international experts of the fine and speciality chemicals industry meet in Munich. From 31 May – 1 June 2017, about 350 exhibitors from 24...
04.04.2017
- Germany’s Merck KGaA has entered a collaboration agreement with UK drug development company Avillion to develop its anti IL-17 A/F Nanobody as a treatment for plaque psoriasis, a...
